Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

Lale Erdem; Lonneke Gravendeel; Jacob Rooi; Paul Eilers; A Idbaih; WGM Spliet; WFA den Dunnen; JL Teepen; P Wesseling; Peter Sillevis Smitt; J.M. Kros; T Gorlia; Martin van den Bent; Pim French

doi:10.1200/JCO.2012.44.1444

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

Lale Erdem, Lonneke Gravendeel, Jacob Rooi, Paul Eilers, A Idbaih, WGM Spliet, WFA den Dunnen, JL Teepen, P Wesseling, Peter Sillevis Smitt, J.M. Kros, T Gorlia, Martin van den Bent, Pim French

Research output: Contribution to journal › Article › Academic › peer-review

92 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	328-336
Number of pages	9
Journal	Journal of Clinical Oncology
Volume	31
Issue number	3
DOIs	https://doi.org/10.1200/JCO.2012.44.1444
Publication status	Published - 2013

Research programs

EMC MM-03-24-01
EMC MM-03-44-06
EMC NIHES-01-66-01

Access to Document

10.1200/JCO.2012.44.1444

http://hdl.handle.net/1765/61225

Cite this

Erdem, L., Gravendeel, L., Rooi, J., Eilers, P., Idbaih, A., Spliet, WGM., den Dunnen, WFA., Teepen, JL., Wesseling, P., Sillevis Smitt, P., Kros, J. M., Gorlia, T., van den Bent, M., & French, P. (2013). Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. Journal of Clinical Oncology, 31(3), 328-336. https://doi.org/10.1200/JCO.2012.44.1444

Erdem, Lale ; Gravendeel, Lonneke ; Rooi, Jacob et al. / Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. In: Journal of Clinical Oncology. 2013 ; Vol. 31, No. 3. pp. 328-336.

@article{a027419296c6447da8420e4204de78f3,

title = "Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951",

author = "Lale Erdem and Lonneke Gravendeel and Jacob Rooi and Paul Eilers and A Idbaih and WGM Spliet and {den Dunnen}, WFA and JL Teepen and P Wesseling and {Sillevis Smitt}, Peter and J.M. Kros and T Gorlia and {van den Bent}, Martin and Pim French",

year = "2013",

doi = "10.1200/JCO.2012.44.1444",

language = "Undefined/Unknown",

volume = "31",

pages = "328--336",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

Erdem, L, Gravendeel, L, Rooi, J, Eilers, P, Idbaih, A, Spliet, WGM, den Dunnen, WFA, Teepen, JL, Wesseling, P, Sillevis Smitt, P, Kros, JM, Gorlia, T, van den Bent, M & French, P 2013, 'Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951', Journal of Clinical Oncology, vol. 31, no. 3, pp. 328-336. https://doi.org/10.1200/JCO.2012.44.1444

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. / Erdem, Lale; Gravendeel, Lonneke; Rooi, Jacob et al.
In: Journal of Clinical Oncology, Vol. 31, No. 3, 2013, p. 328-336.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

AU - Erdem, Lale

AU - Gravendeel, Lonneke

AU - Rooi, Jacob

AU - Eilers, Paul

AU - Idbaih, A

AU - Spliet, WGM

AU - den Dunnen, WFA

AU - Teepen, JL

AU - Wesseling, P

AU - Sillevis Smitt, Peter

AU - Kros, J.M.

AU - Gorlia, T

AU - van den Bent, Martin

AU - French, Pim

PY - 2013

Y1 - 2013

U2 - 10.1200/JCO.2012.44.1444

DO - 10.1200/JCO.2012.44.1444

M3 - Article

C2 - 23269986

SN - 0732-183X

VL - 31

SP - 328

EP - 336

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 3

ER -

Erdem L, Gravendeel L, Rooi J, Eilers P, Idbaih A, Spliet WGM et al. Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. Journal of Clinical Oncology. 2013;31(3):328-336. doi: 10.1200/JCO.2012.44.1444